158 related articles for article (PubMed ID: 11517867)
1. Bladder wall calcification after intravesical chemotherapy with mitomycin C--a case report.
Liu CC; Chou YH; Huang CH; Tsai KB
Kaohsiung J Med Sci; 2001 May; 17(5):274-7. PubMed ID: 11517867
[TBL] [Abstract][Full Text] [Related]
2. [Calcified bladder lesions secondary to the instillation of mitomycin C].
Megias Garrigós J; Pelluch Auladell A; Romero Pérez P; Fernandez García J; Gassó Matoses M; Sánchez Marcos M; Mira Llinarés A
Arch Esp Urol; 1991 Nov; 44(9):1057-60. PubMed ID: 1807206
[TBL] [Abstract][Full Text] [Related]
3. Papillary-like bladder calcifications following intravescical mitomycin C. A case report.
Fiore AA; Iorio B; Vennarecci G; Venditti D; Cervelli V; Giudiceandrea F; Casciani CU
Minerva Urol Nefrol; 1993 Dec; 45(4):171-3. PubMed ID: 8023227
[TBL] [Abstract][Full Text] [Related]
4. Incrusted cystitis after intravesical mitomycin C treatment.
Llopis M; Moreno J; Botella R; Algado M
Acta Urol Belg; 1993 Sep; 61(3):21-3. PubMed ID: 8256682
[TBL] [Abstract][Full Text] [Related]
5. Bladder wall calcification after intravesical mitomycin C treatment of superficial bladder cancer.
Drago PC; Badalament RA; Lucas J; Drago JR
J Urol; 1989 Oct; 142(4):1071-2. PubMed ID: 2507794
[TBL] [Abstract][Full Text] [Related]
6. Intravesical mitomycin C for superficial transitional cell carcinoma.
Bolenz C; Cao Y; Arancibia MF; Trojan L; Alken P; Michel MS
Expert Rev Anticancer Ther; 2006 Aug; 6(8):1273-82. PubMed ID: 16925493
[TBL] [Abstract][Full Text] [Related]
7. Risk of post-operative intravesical mitomycin C instillation following transurethral bladder tumor resection.
Shapiro O; Jones K; Wang C; Landas S; Haas GP
Can J Urol; 2006 Dec; 13(6):3317-20. PubMed ID: 17187694
[TBL] [Abstract][Full Text] [Related]
8. [Calcification of the bladder wall following instillation of mitomycin C. Apropos of a case report].
Pouya M; Van Cangh PJ; Wese FX; Opsomer RJ; Saleh M
Acta Urol Belg; 1995 Dec; 63(4):19-21. PubMed ID: 8644550
[TBL] [Abstract][Full Text] [Related]
9. Intravesical mitomycin C combined with hyperthermia for patients with T1G3 transitional cell carcinoma of the bladder.
Halachmi S; Moskovitz B; Maffezzini M; Conti G; Verweij F; Kedar D; Sandri SD; Nativ O; Colombo R
Urol Oncol; 2011; 29(3):259-64. PubMed ID: 19395285
[TBL] [Abstract][Full Text] [Related]
10. Electromotive instillation of mitomycin immediately before transurethral resection for patients with primary urothelial non-muscle invasive bladder cancer: a randomised controlled trial.
Di Stasi SM; Valenti M; Verri C; Liberati E; Giurioli A; Leprini G; Masedu F; Ricci AR; Micali F; Vespasiani G
Lancet Oncol; 2011 Sep; 12(9):871-9. PubMed ID: 21831711
[TBL] [Abstract][Full Text] [Related]
11. The effect of repeat transurethral resection on recurrence and progression rates in patients with T1 tumors of the bladder who received intravesical mitomycin: a prospective, randomized clinical trial.
Divrik RT; Yildirim U; Zorlu F; Ozen H
J Urol; 2006 May; 175(5):1641-4. PubMed ID: 16600720
[TBL] [Abstract][Full Text] [Related]
12. Bladder wall calcification after topical mitomycin C.
Alter AJ; Malek GH
J Urol; 1987 Nov; 138(5):1239-40. PubMed ID: 3118058
[TBL] [Abstract][Full Text] [Related]
13. Intravesical mitomycin-C-induced interstitial pneumonia.
Wada H; Nakano Y; Yamada H; Saiga T; Yamanaka A; Sakai N
Respiration; 2010; 80(3):256-9. PubMed ID: 20130385
[TBL] [Abstract][Full Text] [Related]
14. Electromotive drug administration with mitomycin C for intravesical treatment of non-muscle invasive transitional cell carcinoma.
Kalsi J; Harland SJ; Feneley MR
Expert Opin Drug Deliv; 2008 Jan; 5(1):137-45. PubMed ID: 18095933
[TBL] [Abstract][Full Text] [Related]
15. Eosinophilic cystitis presenting as a recurrent symptomatic bladder mass following intravesical mitomycin C therapy.
Clark T; Chang SS; Cookson MS
J Urol; 2002 Apr; 167(4):1795. PubMed ID: 11912421
[No Abstract] [Full Text] [Related]
16. Combined local bladder hyperthermia and intravesical chemotherapy for the treatment of high-grade superficial bladder cancer.
Gofrit ON; Shapiro A; Pode D; Sidi A; Nativ O; Leib Z; Witjes JA; van der Heijden AG; Naspro R; Colombo R
Urology; 2004 Mar; 63(3):466-71. PubMed ID: 15028439
[TBL] [Abstract][Full Text] [Related]
17. [Complications of intravesical mitomycin chemotherapy, apropos of 2 clinical case reports].
Pouya M; Opsomer RJ; Wese FX; Saleh M; Donnay M; Van Cangh PJ
Acta Urol Belg; 1996 Mar; 64(1):47-53. PubMed ID: 8659335
[TBL] [Abstract][Full Text] [Related]
18. Histological changes due to intravesical instillation of mitomycin C.
Castillo OA; Landerer E; Feria-Flores M; Vidal-Mora I; Franco C
Arch Esp Urol; 2012 Jun; 65(5):578-82; discussion 582. PubMed ID: 22732786
[TBL] [Abstract][Full Text] [Related]
19. Bladder perforation: a potential risk of early endovesical chemotherapy with mitomycin C.
Racioppi M; Porreca A; Foschi N; Delicato G; Destito A; D'Addessi A
Urol Int; 2005; 75(4):373-5. PubMed ID: 16327311
[TBL] [Abstract][Full Text] [Related]
20. Prospective randomized trial of hexylaminolevulinate photodynamic-assisted transurethral resection of bladder tumour (TURBT) plus single-shot intravesical mitomycin C vs conventional white-light TURBT plus mitomycin C in newly presenting non-muscle-invasive bladder cancer.
O'Brien T; Ray E; Chatterton K; Khan MS; Chandra A; Thomas K
BJU Int; 2013 Dec; 112(8):1096-104. PubMed ID: 24053153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
